The eyesON ICH E6(R3) Interactive Visualizer turns the complex evolution of Good Clinical Practice into a clear, data-driven story. It demonstrates how regulatory thinking has evolved from early ethical foundations, such as the Nuremberg Code, to today’s emphasis on risk proportionality, quality by design, and technology-enabled oversight.
By visualizing regulatory milestones rather than listing them, the tool helps users understand not just what changed in ICH E6(R3), but why those changes matter in modern clinical trial conduct.
The visualizer supports learning and interpretation of regulatory evolution across ethics, quality, risk, and technology.
Track the Evolution of GCP
Compare Guideline Shifts
Learn Through Visual Insights
Each interactive “info snack” breaks down complex regulatory concepts into clear visual comparisons. For example, radar charts illustrate how ICH E6(R3) shifts the emphasis from prescriptive rules to proactive, analytics-supported quality management.
The visualizer is designed to support understanding, discussion, and alignment — whether you are preparing for inspections, updating SOPs, or onboarding teams to new GCP expectations.
How does ICH E6(R3) really differ from E6(R2)?
Explore visual comparisons across quality, risk proportionality, technology integration, and data governance — all in one interactive view.
The ICH E6(R3) Interactive Visualizer is part of Cyntegrity’s eyesON series — a growing collection of free, interactive tools designed to make complex clinical research and regulatory topics easier to explore and apply.
Through the eyesON series, Cyntegrity shares its data analytics expertise and regulatory knowledge with the broader research community. Each visualizer transforms dense guidance and datasets into meaningful visual narratives that support learning, cross-functional dialogue, and practical understanding. Explore More Interactive Visualizers…
See how other datasets can sharpen signal awareness and decision-making.
Need a quote, speaker, or more info about Cyntegrity? Reach out directly to our media contact for timely assistance.
Featured Insights
Start Your Roll-Out
Quick Answers
